• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effects of a calcium antagonist and an angiotensin II receptor antagonist on rat renal arterioles.

作者信息

Kimura K, Tojo A, Hirata Y, Hayakawa H, Goto A, Omata M

机构信息

Second Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.

出版信息

Blood Press Suppl. 1994;5:71-4.

PMID:7889206
Abstract

The objective of this study was to investigate the effects of a dihydropyridine calcium antagonist, manidipine HCl, and an angiotensin II receptor antagonist, CV-11974, on renal microvasculature in hypertensive rats. Hydronephrosis was induced by ligation of the left ureter in 8-week-old stroke-prone spontaneously hypertensive rats. Two months after the operation, the hydronephrotic kidney was split longitudinally and spread out as a thin sheet, and the renal microvasculature was observed directly under a light microscope. Administration of manidipine HCl (20 micrograms/kg) caused a gradual fall in blood pressure (-34 mmHg). The afferent arterioles were dilated, and maintained the same level of dilatation until 30 min (+20%). The efferent arterioles were also dilated (+8%). Glomerular blood flow was significantly increased (+38%). Administration of CV-11974 (100 micrograms/kg) caused a sharp fall in blood pressure at 2 min (-24 mmHg), with a continuous fall in blood pressure until 60 min (-46 mmHg). The afferent arterioles were gradually dilated (+15%). The efferent arteriole was also dilated until 60 min, but to a lesser extent than the afferent arteriole. Glomerular blood flow was immediately increased (+35%). We conclude that both manidipine HCl and CV-11974 dilated both the afferent and efferent arterioles and increased glomerular blood flow.

摘要

相似文献

1
Effects of a calcium antagonist and an angiotensin II receptor antagonist on rat renal arterioles.
Blood Press Suppl. 1994;5:71-4.
2
Renal effects of calcium antagonists with special reference to manidipine hydrochloride.钙拮抗剂对肾脏的影响,特别提及盐酸马尼地平
Blood Press Suppl. 1996;5:10-5.
3
Characterization of the renal action of pranidipine in the rat.
Arzneimittelforschung. 2000 Mar;50(3):248-53. doi: 10.1055/s-0031-1300194.
4
Effect of calcium antagonists on glomerular arterioles in spontaneously hypertensive rats.钙拮抗剂对自发性高血压大鼠肾小球小动脉的作用。
Hypertension. 2000 Mar;35(3):775-9. doi: 10.1161/01.hyp.35.3.775.
5
Effect of a calcium antagonist on renal hemodynamics in salt-loaded spontaneously hypertensive rats.钙拮抗剂对盐负荷自发性高血压大鼠肾血流动力学的影响。
Jpn Heart J. 1995 Nov;36(6):797-805. doi: 10.1536/ihj.36.797.
6
Antihypertensive agents and renal protection: calcium channel blockers.抗高血压药物与肾脏保护:钙通道阻滞剂
Kidney Int Suppl. 1996 Jun;55:S52-6.
7
Effects of manidipine hydrochloride on the renal microcirculation in spontaneously hypertensive rats.
J Cardiovasc Pharmacol. 1992 Dec;20(6):895-9. doi: 10.1097/00005344-199212000-00008.
8
Vasodilatory effect of cilnidipine, an L-type and N-type calcium channel blocker, on rat kidney glomerular arterioles.西尼地平(一种L型和N型钙通道阻滞剂)对大鼠肾脏肾小球小动脉的血管舒张作用。
Int Heart J. 2008 Nov;49(6):723-32. doi: 10.1536/ihj.49.723.
9
Renal vascular responses in spontaneously hypertensive rats chronically treated with manidipine.长期用马尼地平治疗的自发性高血压大鼠的肾血管反应
Blood Press Suppl. 1992;3:60-7.
10
Effects of manidipine on blood pressure and renal function in salt-loaded, spontaneously hypertensive rats.马尼地平对盐负荷自发性高血压大鼠血压和肾功能的影响。
Blood Press Suppl. 1992;3:75-9.

引用本文的文献

1
Chronic Kidney Disease Progression Risk in Patients With Diabetes Mellitus Using Dihydropyridine Calcium Channel Blockers: A Nationwide, Population-Based, Propensity Score Matching Cohort Study.使用二氢吡啶类钙通道阻滞剂的糖尿病患者慢性肾脏病进展风险:一项基于全国人群的倾向评分匹配队列研究
Front Pharmacol. 2022 Mar 9;13:786203. doi: 10.3389/fphar.2022.786203. eCollection 2022.